Yonghong Wan
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Citraconate preserves T cell stemness and antitumor immunity.
Journal: Science immunology
Published: May 01, 2026
Pre-Encoded IFN-I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 11, 2025
A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor.
Journal: Cancer immunology research
Published: January 20, 2025
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells.
Journal: Journal for immunotherapy of cancer
Published: March 13, 2024
The effect of comb length on the in vitro and in vivo properties of self-assembled poly(oligoethylene glycol methacrylate)-based block copolymer nanoparticles.
Journal: Nanoscale advances
Published: December 28, 2023
Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T Cells.
Journal: Cancer immunology research
Published: August 08, 2023
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells.
Journal: Science translational medicine
Published: February 01, 2023
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells.
Journal: Cancers
Published: January 18, 2023
HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden-induced T-cell Exhaustion.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 13, 2022
HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity.
Journal: The Journal of clinical investigation
Published: February 10, 2022
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
Journal: International journal of molecular sciences
Published: December 16, 2021
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity.
Journal: Molecular therapy oncolytics
Published: December 08, 2021
Last Updated: 09/26/2026